Has Eugia Pharma Specialities Limited had other FDA enforcement actions?

Yes. Argus HQ has recorded 3 total FDA actions tied to Eugia Pharma Specialities Limited: 1 warning letter, 0 recalls, 0 approval records, and 2 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Form 483 Inspection Observation, tagged high severity by Argus HQ. FDA published the underlying record on 2026-02-27; Argus observed and indexed it on 2026-07-12.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_483 · inspection_citation · high

Eugia Pharma Specialities Limited -- FDA 483: 4 observations (2026-02-27)

Name: FDA Form 483 Inspection Observation Record — Eugia Pharma Specialities Limited
Creator: Argus HQ
Published: 2026-02-27
License: https://argushq.ai/methodology

Event date: 2026-02-27 00:00:00Z
Observed: 2026-07-12 22:30:47Z
Source ID: 3011960448-2026-02-27-192210
Payload hash: 533baa9c85401068a5be18ce…

Summary

Observation 1: Procedures designed to prevent microbiological contam ination of drug products purporting to be sterile are not established and followed . Specificall y, 1. Environmental and personnel ...

Entities

Eugia Pharma Specialities Limited

View source record ↗

Frequently asked questions

Has Eugia Pharma Specialities Limited had other FDA enforcement actions?: Yes. Argus HQ has recorded 3 total FDA actions tied to Eugia Pharma Specialities Limited: 1 warning letter, 0 recalls, 0 approval records, and 2 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Form 483 Inspection Observation, tagged high severity by Argus HQ. FDA published the underlying record on 2026-02-27; Argus observed and indexed it on 2026-07-12.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Eugia Pharma Specialities Limited -- FDA 483: 4 observations (2026-02-27). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-483-eugia-pharma-specialities-limited-2026-02-27-3011960448

MLA

"Eugia Pharma Specialities Limited -- FDA 483: 4 observations (2026-02-27)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-483-eugia-pharma-specialities-limited-2026-02-27-3011960448.

Chicago

Argus HQ Research. "Eugia Pharma Specialities Limited -- FDA 483: 4 observations (2026-02-27)." Digital Empire Holdings LLC. Accessed August 27, 2026. https://argushq.ai/events/fda-483-eugia-pharma-specialities-limited-2026-02-27-3011960448.

BibTeX

@misc{argushq_argushq_ai_events_fda_483_eugia_pharma_specialities_limited_2026_02_27_3011960448_2026,
  title = {Eugia Pharma Specialities Limited -- FDA 483: 4 observations (2026-02-27)},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-483-eugia-pharma-specialities-limited-2026-02-27-3011960448},
  note = {Accessed: August 27, 2026}
}

Informational only. Not legal, financial, or medical advice.